Maurice Tutor

(5)

$15/per page/Negotiable

About Maurice Tutor

Levels Tought:
Elementary,Middle School,High School,College,University,PHD

Expertise:
Algebra,Applied Sciences See all
Algebra,Applied Sciences,Biology,Calculus,Chemistry,Economics,English,Essay writing,Geography,Geology,Health & Medical,Physics,Science Hide all
Teaching Since: May 2017
Last Sign in: 398 Weeks Ago, 3 Days Ago
Questions Answered: 66690
Tutorials Posted: 66688

Education

  • MCS,PHD
    Argosy University/ Phoniex University/
    Nov-2005 - Oct-2011

Experience

  • Professor
    Phoniex University
    Oct-2001 - Nov-2016

Category > Management Posted 03 Feb 2018 My Price 6.00

Genzyme GelTex

1. Why are Genzyme GelTex looking to set up a joint venture with GelTex for Renagel rather than buying an equity share in GelTex directly? 2. What do you think about the timing of GelTex’s fundraising? Is it a good idea to approach new investors before FDA approval? Please explain your argument. 3. Genzyme is planning to invest $27.5M for 50% in Renagel. Is this a good investment? Please value the joint venture using scenario analysis as in class. a- Assume that the following risks are quantifiable in mid 1997. scientific risk is almost entirely resolved. The likelihood of passing FDA approval is 65%. But the main problem is regulatory delay. for simplicity assume 30% probability of 2 year delay 1. scenario a: Renagel gets FDA approval (with 65% probability) without delay (with 70% probability) 2. scenario b: Renagel gets FDA approval (with 65% probability), but has 2 years delay 3. scenario c: Renagel fails in phase III trails (15%) 4. scenario d: renagel passes phase III trails but in the end FDA does not approve the drug (20%) b. For all other parameters values please use the averages provided in the case

Answers

Maurice Tutor
(5)
Status NEW Posted 03 Feb 2018 06:02 PM My Price 6.00

Hel-----------lo -----------Sir-----------/Ma-----------dam-----------Tha-----------nk -----------You----------- fo-----------r u-----------sin-----------g o-----------ur -----------web-----------sit-----------e a-----------nd -----------acq-----------uis-----------iti-----------on -----------of -----------my -----------pos-----------ted----------- so-----------lut-----------ion-----------.Pl-----------eas-----------e p-----------ing----------- me----------- on-----------cha-----------t I----------- am----------- on-----------lin-----------e o-----------r i-----------nbo-----------x m-----------e a----------- me-----------ssa-----------ge -----------I w-----------ill----------- be-----------

Not Rated(0)